HanBioHanBio

Brand Introduction

Founded in 2010, Hanbio is a high-tech enterprise located in Zhangjiang High-Tech Park, specializing in the research and development and application translation of gene technology. Hanbio has been dedicated to the R&D and production of gene vectors, with core advantage products including lentivirus, adenovirus, and adeno-associated virus. Meanwhile, focusing on hot topics, our services include autophagy flux research tools, virus vector-based CRISPR gene editing tools, non-coding RNA, and luciferase assays, among others. Our self-developed autophagy LC3 dual-labeled adenovirus is a gold-standard research tool in the autophagy field.

To date, our virus products have contributed to over 8,000 publications, among which Hanbio's autophagy virus products have been featured in more than 1,000 academic journal publications, with an average IF > 6.5, including Cell, Cancer Cell, Nature Medicine, Autophagy, Circulation, and other journals.

In the future, we will build on our core gene technology and place greater emphasis on the clinical translation of technology. Hanbio, better gene technology.